Clinical Trials in Oncology (2nd edition, 2003)

sampson2010 · 发表于 2014-8-25 13:45:09

注册后推荐绑定QQ，之后方才可以使用下方的“用QQ帐号登录”。

您需要登录才可以下载或查看，没有账号？立即注册

x

本帖最后由 sampson2010 于 2014-8-25 13:47 编辑

对于本书的详细介绍看这里：http://www.epiman.cn/thread-13369-1-2.html9 R5 h) z6 I4 f7 s" |" H

6 e8 p, H( e, q$ X7 S( s鉴于上面帖子里的附件是分章节挂出，不便于下载阅读，现将整本挂出供大家下载学习～～

Table of contents :
Interdisciplinary Statistics CLINICAL TRIALS in ONCOLOGY, Second Edition......Page 2
Acknowlegdments......Page 29
Contents......Page 24
Contents......Page 0
1.1 A brief history of clinical trials......Page 30
1.2 The Southwest Oncology Group......Page 35
1.3 Example trials......Page 36
1.4 The reason for this book......Page 38
2.1 Introduction......Page 39
2.2 The Phase II trial — estimation......Page 47
2.3 The Phase III trial – hypothesis testing......Page 51
2.3.1 Response as the outcome......Page 52
2.3.2 Survival as the outcome......Page 58
2.4 The proportional hazards model......Page 65
2.5 Sample size calculations......Page 67
2.6 Concluding remarks......Page 68
3.1 Introduction......Page 69
RYRY3 Uligibility treatments endpoints......Page 70
RYRYM Assumptions for sample size calculation......Page 71
RYRYR Traditional designs......Page 76
RYRY3 Newer Phase I designs......Page 77
RYRY: Eonsiderations for biologic agents......Page 80
3.4 Phase II trials......Page 81
RY:YR The Standard Southwest Oncology roup Phase II design......Page 82
activityY......Page 84
not......Page 86
pilot studiesj......Page 89
StratiYcation factors......Page 90
Randomization schemes......Page 91
adaptive allocation......Page 92
intent to treat principle......Page 93
randomized consent designs......Page 94
Placebo’controlled......Page 95
RYMY3 Two’arm trials......Page 97
prove......Page 98
proportional hazards assumptionY......Page 99
Multiple endpoints......Page 100
proving......Page 101
3.6 Conclusion......Page 104
4.1 Introduction......Page 106
4.2 Types of multi-arm trials......Page 107
4.3 Significance level......Page 110
4.4 Power......Page 111
5.1 Planned interim analyses......Page 123
5.2 Data monitoring committees: Rationale and responsibilities......Page 129
5.3 Monitoring committees: Composition......Page 133
5.4 Examples......Page 138
5.5 Concluding remarks......Page 148
6.1 Introduction: Why worry?......Page 149
6.2 Protocol development......Page 154
6.3 Data collection......Page 162
6.4 Protocol management and evaluation......Page 169
6.5 Quality assurance audits......Page 175
6.6 Training......Page 176
6.7 Data base management......Page 177
6.8 Conclusion......Page 180
6.9 Appendix: Examples......Page 181
CHAPTER 7: Reporting of Results......Page 190
7.1 Timing of report......Page 191
7.2 Required information......Page 193
7.3 Analyses......Page 195
7.4 Conclusion......Page 204
8.2 Historical controls......Page 205
8.3 Competing risks......Page 212
8.4 Outcome by outcome analyses......Page 219
8.5 Subset analyses......Page 227
8.6 Surrogate endpoints......Page 230
9.1 Introduction......Page 233
9.2 Some background and notation......Page 234
9.3 Identification of prognostic factors......Page 236
9.4 Forming prognostic groups......Page 243
9.5 Analysis of microarray data......Page 248
9.6 Meta-Analysis......Page 250
9.7 Concluding remarks......Page 256
CHAPTER 10: Summary and Conclusions......Page 257
Bibliography......Page 4

Clinical Trials in Oncology (2nd edition, 2003).pdf (2.19 MB, 下载次数: 39)

来自群组: RGCE

账号		自动登录	找回密码
密码			立即注册

[分享] Clinical Trials in Oncology (2nd edition, 2003)

注册后推荐绑定QQ，之后方才可以使用下方的“用QQ帐号登录”。

本帖被以下淘专辑推荐: